CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 30 enrolled
Drug / intervention
Continuous Glucose Monitor +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05074667
NCT05074667N/ACompleted

Use of Continuous Glucose Monitors in Publicly-Insured Youth With Type 2 Diabetes - A Pilot and Feasibility Study

Stanford University·interventional·Posted Oct 12, 2021·Updated Jul 31, 2024

In Brief

A clinical study evaluating Continuous Glucose Monitor and Patient Reported Outcome Questionnaires for Type 2 Diabetes. Completed, enrolled 30 participants across 1 site.

Detailed Summary

The purpose of this pilot feasibility study is to provide continued CGM access to youth with type 2 diabetes and collect descriptive data about feasibility of use of CGM in youth with type 2 diabetes ages 4 years and older. From this study the investigators hope to learn if CGM use in youth with type 2 diabetes can be tolerated and sustained with good adherence and to describe blood glucose patterns in youth with type 2 diabetes. The primary aim will be to evaluate the feasibility of CGM start and continuation in youth with T2D and describe glucose metrics and patient reported outcomes (PROs). The investigators will pilot and refine a program to test the hypothesis that CGM start and continuation in youth with T2D is feasible and then evaluate glucose metrics and PROs.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 2 Diabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedOct 12, 2021
Enrollment StartDec 1, 2021
Primary CompletionJun 25, 2023
TodayJul 2, 2026
Enrollment to primary: 1.6 yearsPosted 4.7 years ago

Interventions

Continuous Glucose Monitordevice

Participants will be provided a continuous glucose monitor for use in self-glucose monitoring as per standard clinical care

Patient Reported Outcome Questionnairesother

Participants and their parents will be asked to complete patient reported outcome questionnaires at 3 study time points.